CoS
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
05 Jul 2024
05 Jul 2024
Historique:
received:
31
05
2024
accepted:
28
06
2024
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
8
7
2024
Statut:
epublish
Résumé
Cardiovascular diseases caused by atherosclerosis (AS) seriously damage human health. Nano-photothermal technology has been proven to inhibit the development of vascular inflammation by inhibiting the proliferation of inflammatory macrophages. However, photothermal therapy can inhibit the enrichment of AS macrophages in the early stage, but the inhibitory effect is insufficient in the later stage. Herein, we designed and prepared CoS
Identifiants
pubmed: 38974227
doi: 10.1039/d4ra04006f
pii: d4ra04006f
pmc: PMC11224947
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21241-21249Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There is no conflict of interest to declare.